Transaction in Own Shares

Summary by AI BETAClose X

GSK plc announced the purchase of 340,000 of its own ordinary shares, with a nominal value of 31¼ pence each, on October 13, 2025. The shares were bought through BNP Paribas SA at prices ranging from 1,614.50p to 1,633.00p per share, with a volume-weighted average price of 1,623.26p. These shares will be held as treasury shares, forming part of an existing buyback program. Since September 30, 2025, GSK has purchased 3,244,000 ordinary shares. Following this transaction, the company holds 250,708,844 ordinary shares in treasury and has 4,064,704,985 ordinary shares in issue, excluding treasury shares; the treasury shares represent 6.17 percent of voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings